EMA Survey on the use of social media and medicines (Deadline: 23 November 2014)
The European Medicines Agency has launched a survey to explore people's use of social media and whether they discuss adverse events/drug reactions/side-effects on social media platforms, including questions on how social media communications could be used to collect data on adverse reactions and how people feel about that.
Participate in the survey
The survey is accessible by clicking on this link:
The survey should take no longer than 15-20 minutes to complete. Deadline to participate is 23 November 2014.
About the survey
The survey is taking place within the framework of the IMI WEB-RADR project, which aims to explore the use of mobile technologies and social media to enhance the way we promote safe use of medicines.
WEB-RADR is a three-year research project and includes European medicines regulators (including the EMA), academics and the pharmaceutical industry. It is funded through the Innovative Medicines Initiative, a public private partnership between the European Commission and the European Federation of Pharmaceutical Industries and Associations.